Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imperial Malts is a prominent Indian manufacturer and exporter of malt and malt extracts, serving the food, beverage, and pharmaceutical sectors. The company produces a variety of malt-based ingredients, including liquid and powdered extracts, which are used in the healthcare industry as nutritional supplements and as flavoring or binding agents in pharmaceutical formulations. Established in 1981, Imperial Malts operates modern manufacturing facilities that adhere to international quality standards, providing essential ingredients for health drinks and medicinal syrups globally. Their products are utilized by major pharmaceutical companies for the production of tonics and pediatric medicines. The company maintains a strong focus on quality control, with certifications including ISO 9001 and ISO 22000, ensuring their extracts meet the rigorous demands of the life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imperial Malts.